Directors Report Enabling Everywhere | Filtrona plc Annual Report 2012 Business Review | Filtrona at a Glance 3 $POUSJCVUJPO UP SPVQ 2 1,2 2012 2012 Operating divisions Revenute % Operating profit % 1.
Other 3.5 1.3 5 5 Other 4 Relates to the Enitor plastic prole extrusion business 1 in The Netherlands.
1 4 3 2 3 2 $PBUFE 4FDVSJUZ 1SPEVDUT 'JMUFS 1SPEVDUT The global market leading producer of high quality self-adhesive tear The only global independent cigarette lter supplier.
The nine tape and a growing supplier of labels, products and technologies for worldwide locations, including a UK-based research facility and the consumer packaging, identity and valuable documents markets.
three regional development centres provide a exible infrastructure Customers in over 100 countries are served from facilities operating strategically positioned to serve the tobacco industry.
The division in five countries.
supplies a wide range of value-adding high quality innovative lters, packaging solutions to the roll your own sector and analytical IJHIMJHIUT laboratory services for ingredient measurement for the industry.
t Further growth in tear tape and label-based packaging solutions, IJHIMJHIUT and authentication t Continued recognition for innovation, winning an Asian t Excellent growth, supported by successful new products and Manufacturing Award 2012 and a UK IT Industry Award additional service offerings t Additional investment in authentication technologies and t Strong performance across customer base, including independents manufacturing capability t Increase in proprietary products launched and bespoke customer t Successful delivery of Blue Badge scheme in the UK, and international development activity contract wins for identity solutions t Continued innovation to capture growth trend in special lters t Provision of secure accreditation solutions to the London 2012 Games t significant investment in scientific Services capability t Integration of Securit acquisition t New talent management framework introduced 85.3m 14.9m 233.6m 28.9m 1 1 Revenue Operating profit Revenue Operating profit 17.5% 10.4% 12.3% 18.0% 5 4 Revenue by end-market % 4 Sales volume by type % 1.
"Other 0.4 2 2 1 Before intangible amortisation and exceptional operating items 2 Adjusted to reect the impact of eliminations and excluding central costs 4 Filtrona plc Annual Report 2012 8F ""SF FSF 0VS QSPEVDUT NBZ OPU CF OPUJDFBCMF o PS FWFO JOTUBOUMZ SFDPHOJTBCMF o CVU XIFSFWFS ZPV BSF PVS CVTJOFTT JT BMM BSPVOE ZPV Wound care Our innovative medical grade wound care dressings are highly absorbent and ultra pure Special lters New lter technologies, such as the Corinthian, provide visual and performance differentiation"
